No Data
INT MEDICAL: Annual Report 2024
China Securities Co.,Ltd.: It is recommended to focus on the new growth and integration opportunities in the Industry.
China Securities Co.,Ltd. remains bullish on high-quality Innovative Drugs companies in 2025 and actively focuses on cutting-edge technologies in pharmaceuticals and medical devices.
INT MEDICAL (01501) announced the 2024 financial results with a net profit of approximately 0.19 billion yuan, a year-on-year increase of 24.03%.
INT MEDICAL (01501) announced its 2024 performance, with revenue of approximately 0.852 billion yuan, a year-on-year growth of 13.17%...
Express News | Shanghai Int Medical Instruments FY Revenue RMB 851.95 Million
Express News | Shanghai Int Medical Instruments FY Gross Margin 63.11%
Express News | Shanghai Int Medical Instruments FY Gross Profit RMB 537.66 Million
This Analyst Just Downgraded Their Shanghai INT Medical Instruments Co., Ltd. (HKG:1501) EPS Forecasts